1. |
Shiraga K, Sakaguchi K, Senoh T, et al. Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicinresistant sublines [J]. J Gastroenterol Hepatol, 2001; 16(4)∶460.
|
2. |
程國鈞, 李亞里, 田方, 等. 不同方式誘導人卵巢癌順鉑耐藥細胞株的比較 [J]. 中華腫瘤雜志, 2001; 23(4)∶305.
|
3. |
陸家齊, 陸連榮, 蔣彥和, 等. PdGC81 人體胃底分化腺癌細胞系的建立及其生物學特征的觀察 [J]. 中華腫瘤雜志, 1986; 8(1)∶4.
|
4. |
趙憲琪. 乳腺癌細胞系的建立與應用研究 [J]. 實用腫瘤學雜志, 2001; 15(3)∶239.
|
5. |
Chauffert B, Martin M, Hammann A, et al. Amiodaroneinduced enhancement of doxorubicin and 4’deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo [J]. Cancer Res, 1986; 46(2)∶825.
|
6. |
Twentyman PR, Fox NE, Wright KA, et al. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells [J]. Br J Cancer, 1986; 53(4)∶529.
|
7. |
梁永鋸, 周肵熙, 潘啟超, 等. 肝癌體外藥敏感性試驗 [J]. 腫瘤, 2001; 21(1)∶17.
|
8. |
Flens MJ, Zaman GJ, van der Valk P, et al. Tissue distribution of the multidrug resistance protein [J]. Am J Pathol, 1996; 148(4)∶1237.
|
9. |
McGovern F, Kachel T, Vijan S, et al. Establishment and characterization of a doxorubicinresistant human bladder cancer cell line (MGHU1R) [J]. J Urol, 1988; 140(2)∶410.
|
10. |
Keizer HG, Schuurhuis GJ, Broxterman HJ, et al. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased Pglycoprotein expression in cultured SW1573 human lung tumor cells [J]. Cancer Res, 1989; 49(11)∶2988.
|
11. |
Kaye SB. The multidrug resistance phenotype [J]. Br J Cancer, 1988; 58(6)∶691.
|
12. |
Harker WG, Sikic BI. Multidrug (pleiotropic) resistance in doxorubicinselected variants of the human sarcoma cell line MESSA [J]. Cancer Res, 1985; 45(9)∶4091.
|